These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6611198

  • 1. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
    Sato A, Montgomery JA, Cory JG.
    Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198
    [Abstract] [Full Text] [Related]

  • 2. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
    Sato A, Carter GL, Bacon PE, Cory JG.
    Cancer Res; 1982 Nov; 42(11):4353-7. PubMed ID: 6751522
    [Abstract] [Full Text] [Related]

  • 3. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG, Carter GL.
    Cancer Res; 1988 Feb 15; 48(4):839-43. PubMed ID: 3276399
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR, Jacobsen DM, Chang CH, Brockman RW, Sirotnak FM.
    Cancer Res; 1987 Feb 01; 47(3):700-6. PubMed ID: 3802076
    [Abstract] [Full Text] [Related]

  • 9. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist JA, Bennett LL.
    Cancer Res; 1991 May 01; 51(9):2386-94. PubMed ID: 1707752
    [Abstract] [Full Text] [Related]

  • 10. Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture.
    Sato A, Carter GL, Bacon PE, Cory JG.
    Adv Enzyme Regul; 1983 May 01; 21():259-70. PubMed ID: 6400064
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 01; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 12. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W, Cohen SS.
    Cancer Res; 1975 Jun 01; 35(6):1547-54. PubMed ID: 1079475
    [Abstract] [Full Text] [Related]

  • 13. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE, Selner M, Phillips JR.
    Cancer Res; 1983 Oct 01; 43(10):4791-8. PubMed ID: 6603904
    [Abstract] [Full Text] [Related]

  • 14. Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.
    Yoshio N, Kawai Y, Hori H, Ueda T.
    Int J Hematol; 2005 Jun 01; 81(5):405-12. PubMed ID: 16158821
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
    Matsumoto M, Weckbecker G, Cory JG.
    Cancer Commun; 1990 Jun 01; 2(1):1-6. PubMed ID: 2369548
    [Abstract] [Full Text] [Related]

  • 16. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
    Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K.
    Leukemia; 2000 Mar 01; 14(3):379-88. PubMed ID: 10720130
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul 01; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 18. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC, Derse D, Cheng YC, Brockman RW, Bennett LL.
    Mol Pharmacol; 1982 Mar 01; 21(2):474-7. PubMed ID: 7048062
    [Abstract] [Full Text] [Related]

  • 19. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep 01; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.